Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Linical Co., Ltd. ( (JP:2183) ) has provided an update.
Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.
More about Linical Co., Ltd.
Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the clinical research industry. It focuses on providing services related to drug development and clinical trials, catering to the pharmaceutical and biotechnology sectors.
Average Trading Volume: 50,056
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.71B
See more data about 2183 stock on TipRanks’ Stock Analysis page.